Propanolamine derivatives having anti-diabetic effects

Details Propanolamine derivatives having anti-diabetic effects Propanolamine derivatives having anti-diabetic effects

1990-10-31

1991-09-03

Hollrah, Glennon H.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514 95, 514357, 514567, 514653, 546334, 546335, 549 75, 560 42, 562451, 564336, 564355, A61K 3124, A61K 31135, C07C22934, C07C21508

Patent

active

050455672

ABSTRACT:
Propanolamine derivatives of the formula ##STR1## wherein R.sup.1 is hydrogen or a group of formula ##STR2## n is the number 0 or 1; R.sup.2 and R.sup.5 are phenyl, m-halophenyl, m-trifluoromethylphenyl, thienyl or pyridyl;

REFERENCES:
patent: 3804899 (1974-04-01), Ebnother et al.
patent: 4585796 (1986-04-01), Alig et al.
patent: 4692465 (1987-09-01), Hindley et al.
patent: 4743604 (1988-05-01), Alig et al.
patent: 4800206 (1989-01-01), Alig et al.
patent: 4803293 (1989-02-01), Berge et al.
patent: 4820717 (1989-04-01), Mosse et al.
patent: 4871755 (1989-10-01), Alig et al.
patent: 4892886 (1990-01-01), Alig et al.
Jen et al., Adrenergic Agents, J. Med. Chem., vol. 20, No. 5, 693-698 (1977).
Kienzle, F., CA, vol. 112, 234956z, 1990.

Affiliated with

Also associated with

Rating

Propanolamine derivatives having anti-diabetic effects does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Propanolamine derivatives having anti-diabetic effects, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Propanolamine derivatives having anti-diabetic effects will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1009729